Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Fish and Richardson
Cerilliant
Teva
Citi
Merck
McKesson
Medtronic

Generated: October 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PULMICORT FLEXHALER

« Back to Dashboard

Clinical Trials for PULMICORT FLEXHALER

Trial ID Title Status Sponsor Phase Summary
NCT00702325 Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans Completed AstraZeneca Phase 4 To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.
NCT01218399 Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations Completed AstraZeneca N/A This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with Stanford staff. We hypothesize that the budesonide/formoterol combination improves the efficacy of budesonide alone.
NCT01218399 Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations Completed Stanford University N/A This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with Stanford staff. We hypothesize that the budesonide/formoterol combination improves the efficacy of budesonide alone.
NCT01219738 Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide Completed AstraZeneca N/A Glucocorticosteroids recently have been shown to have non-genomic actions that are plasma membrane-mediated and do not require gene transcription and translation. One of these non-genomic effects is the inhibition of adrenergic agonist transport into airway vascular smooth muscle cells with an increase of adrenergic agonist concentrations at adrenergic receptor sites and enhance the physiological effects of endogenous adrenergic agonists (e.g. locally released norepinephrine from noradrenergic neurons) or exogenous adrenergic agonists (e.g. inhaled beta-adrenergic agonists).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for PULMICORT FLEXHALER

Condition Name

Condition Name for PULMICORT FLEXHALER
Intervention Trials
Asthma 4
Osteoporosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for PULMICORT FLEXHALER
Intervention Trials
Asthma 3
Osteoporosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for PULMICORT FLEXHALER

Trials by Country

Trials by Country for PULMICORT FLEXHALER
Location Trials
United States 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for PULMICORT FLEXHALER
Location Trials
Pennsylvania 2
Florida 2
California 2
New York 2
Georgia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for PULMICORT FLEXHALER

Clinical Trial Phase

Clinical Trial Phase for PULMICORT FLEXHALER
Clinical Trial Phase Trials
Phase 4 3
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for PULMICORT FLEXHALER
Clinical Trial Phase Trials
Completed 4
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for PULMICORT FLEXHALER

Sponsor Name

Sponsor Name for PULMICORT FLEXHALER
Sponsor Trials
AstraZeneca 3
West Penn Allegheny Health System 1
University of Miami 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for PULMICORT FLEXHALER
Sponsor Trials
Other 4
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Merck
Cipla
Chubb
Harvard Business School
UBS
Healthtrust
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.